Lotte K. Kristensen

CD4⁺ and CD8a⁺ PET imaging predicts response to novel PD-1 checkpoint inhibitor: studies of Sym021 in syngeneic mouse cancer models

Lotte K. Kristensen, Camilla Fröhlich, Camilla L. Christensen et al. · Theranostics · 2019 · 105 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody

Camilla L. Christensen, Lotte K. Kristensen, Maria Z. Alfsen et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 83 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Site-specifically labeled ⁸⁹Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model

Lotte K. Kristensen, Camilla L. Christensen, Mette Munk Jensen et al. · Theranostics · 2019 · 70 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Genetic ablation of soluble tumor necrosis factor with preservation of membrane tumor necrosis factor is associated with neuroprotection after focal cerebral ischemia

Pernille M. Madsen, Bettina Hjelm Clausen, Matilda Degn et al. · Journal of Cerebral Blood Flow & Metabolism · 2015 · 56 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Monitoring CD8a+ T Cell Responses to Radiotherapy and CTLA-4 Blockade Using [64Cu]NOTA-CD8a PET Imaging

Lotte K. Kristensen, Camilla L. Christensen, Maria Z. Alfsen et al. · Molecular Imaging and Biology · 2020 · 37 citations · Full text

Medicine, Nuclear Medicine, Oncology +17